This literature shall NOT operate as permission, recommendation, or inducement to practice any patented invention without permission of the patent owner. 1.844.4AVIENT www.avient.com TEST STANDARD UNIT SYNCURE™ XLPE S1054A ROHS NATURAL Specific Gravity ASTM D1505 – 0.919 Melt Flow Index, 190°C/2.16kg ASTM D1238 g/10min 1.045 Tensile Strength at Break ASTM D638 psi 2500 Tensile Elongation at Break ASTM D638 % 450 Delta Torque Internal g-m 2154 Moisture Content ASTM D2974 % 0.0004 Gel Content ASTM D2765 % 73 Hot Creep Elongation UL 2556 % 49 Hot Deformation UL 2556 % 6 TECHNICAL PROPERTIES *Gel Content, Hot Creep Elongation and Hot Deformation measured on 95 phr S1054A / 5 phr S100B system, and cured by autoclave for 9 hours

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. Use of Non-GAAP Measures Page 3 -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Page 4 All time high of $32.32 October 21st, 2013 • 16 consecutive quarters of double digit EPS growth • 42% CAGR adjusted EPS expansion 2006-2012 • YTD stock price has increased 56% versus 22% growth in the S&P • Six fold increase in market cap: $0.5b $3.0b Strategy and Execution Drive Results PP&S 15% Specialty 60% Distribution 25% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010* 2011* 2012* 2015 Target A dj us te d Ea rn in gs P er S ha re Appliance 6% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 4% Consumer 9% Packaging 18% Industrial 10% Misc. 5% HealthCare 9% Transportation 16% Textiles 1% United States 70% Europe 14% Canada 8% Asia 5% Latin America 3% 2012 Revenues: $4.0 Billion* End Markets* 2012 Revenues: $4.0 Billion* EPS Page 5 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms & excludes discontinued operations PolyOne At A Glance * Restated to exclude discontinued operations Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 63% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 YTD 2013 2015 % o f O pe ra ti ng In co m e* JV's PP&S Distribution Specialty Specialty OI $5M $46M $87M $153M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 6 2006 YTD 2013 2015 Where we were Where we are Organic Consolidated Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.8% 12.8% 12 – 16% Global Specialty Engineered Materials 1.1% 10.8% 8.9% 12 – 16% Designed Structures & Solutions — — 5.0% 8 – 10% Performance Products & Solutions 5.5% 8.0% 8.2% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 63% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 28% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 7 *Percentage of Specialty Platform revenue from products introduced in last five years 19.5% 44.0% 2006 Q3 2013 $20.3 $46.6 2006 TTM Q3'13 14.3% 31.0% 2006 Q3 2013 Research & Development Spending Specialty Platform Vitality Index Progression* Innovation Drives Earnings Growth ($ millions) Specialty Platform Gross Margin % Page 8 We are Experts in Polymer Science and Formulation  Polymer Science  Formulation  Chemistry  Processing Inputs  Base Resins  Additives  Modifiers  Colorants Specialized Polymer Materials, Services, and Solutions Expertise Satisfied Consumers PolyOne Customer Innovative Products & Services  Marketplace Demands  Performance Requirements  Value Drivers Page 9 Positioned for Strong Growth 2015 Target Rev: $5B Adj. EPS: $2.50 Assumptions • Mid single digit revenue CAGR • Operating margins in mid-range of 2015 targets • No global recession • No investment in incremental PP&S capacity • Housing starts at 85% of 50 year norm by 2015 • Remain comfortably below 3X Net Debt / EBITDA Page 10 2012 Rev: $2.9B Adj.

April 3, 2024 PCR Color Prediction Service: a digital tool that can illustrate the color possibilities or limitations of certain types of recycled resins (PCR) prior to laboratory trials, which can help simplify the overall color decision-making process during product development and launch Avient will exhibit at Propak Vietnam 2024 on April 3-5, 2024, in Hall A1, Stand AT6.  

3. Digital prototyping and testing can eliminate the need for early physical versions.

These products have high-strength, low stretch, and excellent fatigue properties, and are properly torque-balanced for optimal performance.

S E C O N D Q U A R T E R 2 0 2 2 R E S U L T S $122 $134 2021 2022 $0.87 $0.98 2021 2022 Q2 2022 PERFORMANCE ( T O TA L C O M PA N Y ) 4 Sales Adjusted Operating Income $1,235 $1,302 2021 2022 + 5% Adjusted EPS + 10% + 13% (in millions) (in millions) (+ 10% excluding FX) (+ 16% excluding FX) (+ 20% excluding FX) Q2 2022 SEGMENT PERFORMANCE 5 CAI $624 $649 Sales ($ in millions) SEM Distribution $86 $94 Operating Income + 4% + 9% $404 $443 Sales $24 $27 Operating Income + 10% + 13% (1) $241 $244 Sales $37 $37 Operating Income + 1% Flat (+ 10% excluding FX) (+ 16% excluding FX) (+ 6% excluding FX) (+ 3% excluding FX) Q2 2021 $1,235 $122 Sustainable Solutions 17 7% 7 Healthcare 23 14% 5 Composites (ex Outdoor High Performance) 10 20% 4 Growth in Asia / LATAM 5 3% 1 Other 69 11% 5 Sub-total $1,359 10% $144 Outdoor High Performance Impact (9) (5) Wage Inflation and Overtime (7) Other Supply Chain Costs (2) Clariant Color Integration Synergies 7 Incentives, Other Employee Costs 4 FX (48) (7) Q2 2022 $1,302 5% $134 Q2 2022 SALES AND OPERATING INCOME ( T O TA L C O M PA N Y ) 6 Sales Growth Rate Adjusted Operating Income$ millions Adjusted EBITDA Q2 EBITDA BRIDGE 7 Price increases more than offsets raw material and supply chain impacts Q2 2021 $ 159 Demand (29) $ millions CAI: Price / Mix 87 Inflation (58) SEM: Price / Mix 36 Inflation (24) Distribution: Price / Mix 45 Inflation (41) Net Price Benefit 45 Wage Inflation and Overtime (7) Other Supply Chain Costs (2) Clariant Color Integration Synergies 7 Incentives, Other Employee Costs 4 FX (7) Q2 2022 $ 170   China Lockdowns / Russia Impact $ (14) Outdoor High Performance (5) Transportation (5)  8 Q2 '21 Adjusted EPS 0.87$ Color, Additives and Inks 0.11 Specialty Engineered Materials 0.01 Distribution 0.03 Corporate Costs 0.01 F/X (0.05) Segment OI 0.11$ Interest Expense 0.03 Tax Rate (0.03) Q2 '22 Adjusted EPS 0.98$ Q2 EPS BRIDGE Key Updates • Provided progress on 2030 Sustainability Goals • Emphasized commitment to U.N. D I S T R I B U T I O N ) 18 END-MARKET F OCUS F OR NEW I NNOVATION Semiconductors Robotics Healthcare Interconnected disruptive markets with massive innovation needs 19 APPENDIX Performance Additives 15% Pigments 13% TiO2 11% Dyestuffs 3%Polyethylene 12% Nylon 6% Polypropylene 5% Other Raw Materials 30% Styrenic Block Copolymer 5% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials 22 • Significant raw material price inflation and tight inventory continued in Q2 2022, although at a slightly lesser rate compared to the prior quarter o For Q2 2022, the average cost of key hydrocarbon based materials was up 15%, roughly the same as the average cost of non- hydrocarbon based materials Annual Purchases RAW MATERIAL AND SUPPLY CHAIN UPDATE Based on 2021 purchases, excludes Distribution business SEGMENT DATA U.S. & Canada 50% EMEA 25% Asia 16% Latin America 9% 2021 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 23% Packaging 19% Industrial 16% Building and Construction 10% Telecommunications 4% Energy 2% END MARKET REVENUE (1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs $2,402M $409M $919M $164M $1,631M $94M Sales EBITDA Distribution Specialty Engineered Materials Color Additives and Inks $581M$4,819M (1) Transportation 11% Healthcare 15% 24 Packaging 34% Consumer 21% Healthcare 8% Industrial 16% Building & Construction 10% Transportation 9% Energy 1% Telecommunications 1% C O L O R , A D D I T I V E S & I N K S 2 0 2 1 R E V E N U E | $ 2 . 4 B I L L I O N US & Canada 32% EMEA 40% Asia 21% Latin America 7% END MARKET REGION 25 All charts reflect 2021 financials S P E C I A L T Y E N G I N E E R E D M A T E R I A L S Consumer 27% Healthcare 10% Packaging 7% Telecommunications 16% Transportation 11% Industrial 11% Building & Construction 11% Energy 7% 2 0 2 1 R E V E N U E | $ 9 1 9 M I L L I O N END MARKET US & Canada 55% EMEA 25% Asia 20% REGION 26 All charts reflect 2021 financials D I S T R I B U T I O N Healthcare 26% Consumer 23% Packaging 5% Industrial 20% Transportation 16% Building and Construction 8% Energy 1% Telecommunications 1% US & Canada 80% Asia 3% Latin America 17% END MARKET REGION K E Y S U P P L I E R S 2 0 2 1 R E V E N U E | $ 1 . 6 B I L L I O N 27 All charts reflect 2021 financials T O T A L C O M P A N Y R E G I O N A L S A L E S B Y E N D M A R K E T Packaging 30% Consumer 26%Healthcare 13% Industrial 14% Building & Construction 5% Telecommunications 2% Energy 2% Asia (16% of sales) Transportation 8% Packaging 32% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 12% Telecommunications 5% Energy 4% EMEA (25% of sales) Transportation 12% 28 Consumer 25% Healthcare 19% Packaging 10% Industrial 17% Building & Construction 10% Telecommunications 4% Energy 2% US & Canada (50% of sales) Transportation 13% Packaging 38% Consumer 33% Healthcare 8% Industrial 10% Building & Construction 5% Telecommunications 1% LATAM (9% of sales) Transportation 5% All charts reflect 2021 financials Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. W H Y AV I E N T W I N S Deep Customer Relationships & Application Know-How Superior Design Capabilities & Advanced Analytics Global Footprint Strategically Aligned to Serve Customers We iterate fast and often. 38 22 9 34 • U.S. and Canada • Latin America • Europe, Middle East & Africa • Asia We produce locally, serve globally. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 26 Capex / Revenue 2021E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 4 3 3 3 4 4 5 5 5 6 7 7 8 24 A vi e n t A vi e n t (E xc l.

Injection molding parameters and troubleshooting recommendations for the the Nymax™ prime and Nymax™ REC recycled nylon materials Injection molding parameters and troubleshooting recommendations for Gravi-Tech™ Injection molding parameters and troubleshooting recommendations for Gravi-Tech™ (Chinese language version)  

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. Develop and implement solutions to end plastic waste while supporting AEPW $1.5B investment in key initiatives. 2 0 3 0 S U STA I NA B I L I T Y TA RG E TS 26 2 0 2 1 AV I E N T I N V E S TO R DAY 27 • Investor Day to be held December 9, 2021 in New York, NY • Company will provide updates on its key growth drivers with a deep focus on sustainable solutions Revenue Growth Drivers Long-Term Growth Rate Sustainable Solutions 8–12% Healthcare 8–10% Composites / 5G 10% Growth in Asia / LATAM 5% Other (GDP growth) 2–3% Avient 6.5% • Senior leadership team to also present on Clariant MB integration, M&A opportunities and capital allocation priorities PEER COMPARISONS 28 As a specialty formulator, we don’t require significant capital investment, as compared to the base resin raw material suppliers we purchase from. Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 29 Capex / Revenue 2021E (%) AV I E N T I S A SS E T L I G H T Avient Specialty Formulators Other Chemical/Specialty Companies 2 2 2 2 3 3 3 4 3 4 4 5 5 5 5 5 6 7 27 A vi e n t A vi e n t (E xc l.

You are advised  to consult any further disclosures we make on related subjects in our reports on Form 10‐Q, 8‐K and 10‐K that we provide to the Securities and Exchange  Commission. Page 3 Strategy and Execution Drive Results 90% $22 $24 PolyOne Stock Price 50% 70% $18 $20 $22 S&P 500 (relative performance) 30% $12 $14 $16 S&P 500 (relative performance) ‐10% 10% $6 $8 $10 50% ‐30% $0 $2 $4 $ | ‐50%$0 2006 2007 2008 2009 2010 2011 2012 2013 Page 4 Four Pillar Strategy The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized  Polymer Materials, Services & Solutions Page 5 Spartech – Compelling Strategic Rationale • Spartech expands PolyOne’s specialty portfolio with adjacent  technologies in attractive end markets  Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only  6% of Spartech’s revenues are outside of North America • PolyOne has a proven management team with a track record of  transformational success • Preliminary synergy estimated at $65 million run rate by end of  3year 3  Significant opportunity to expand profitability by leveraging  PolyOne’s four pillar strategy • Substantial potential share price appreciation for all  shareholders f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once  synergies realized Page 6 Mix Shift Highlights Specialty Transformation  Old  PolyOne Transformation 100% 2015 Target 80% In co m e*   65 – 75%40% 60% f O pe ra ti ng   34% 43% 45% 65  75% 20% %  o f 2%0% 2005 2008 2010 2012 2015 Specialty OI $5M   $46M                        $87M                       $114M                     Target *Operating Income excludes corporate charges and special items JV's PP&S Distribution Specialty Page 7 Proof of Performance 2007 2012 2015 “Where we were” “Where we are” “Where we  Where we were Where we are expect to be" 1)  Operating Income % Specialty 3.2% 9.1% 12 – 16% PP&S 6.1% 9.0% 9 – 12% Distribution 3.0% 6.4% 6 – 7.5% 2)  Specialty Platform sss% of Operating Income 20% 45% 65 – 75% 3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15% 4)  Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit  Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period **4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS Page 8 Proof of Performance Spartech Opportunity Intermediate  PolyOne Spartech Opportunity 2006 2012 Today Goal “Where we were” “Where we are” “Where  Spartech is”* “Where we can go”were are Spartech is can go Specialty Operating Margin 1.5% 9.1% 2.2% 8.0% – 10.0%  Margin Page 9 *Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012 At a Glance PolyOne Europe 14% Canada 8% Asia 5% Latin America 3% Distribution 2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion* United States 70% 14% 5% PP&S 20%Specialty 57% 23% 70% Appliance 5% Building & HealthCare Transportation 16% Textiles 2% 1.02 1.20 $1.20 $1.40 ha re End Markets* EPS Growth g Construction 14% Wire & Cable 8% Consumer 8% Packaging 17% Industrial 11% Misc. 6% 9% 0.27 0 21 0.79 $0.40 $0.60 $0.80 $1.00 A dj us te d  Ea rn in gs  P er  S Electrical & Electronics 4% 0.12 0.21 0.13 $0.00 $0.20 2006 2007 2008 2009 2010 2011 2012 Page 10 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms At a Glance Specialty U it d 2012 Revenues: $2.4 Billion* Solutions United States 59% Europe 23% Asia Canada 4% Asia 9% Latin America 5% Appliance 4% Building & C t ti HealthCare 5% Transportation 16% Textiles 2% %   o f S al es 12-16% End Markets* Expanding Profits Construction 11% Wire & Cable 7% Electrical & Electronics Packaging 23% Industrial 7% Misc. 15% 1.5% 3.2% 4.3% 5.3% 8.4% 9.1% O pe ra ti ng  In co m e  % 8.0% Electronics 4% Consumer 6% Page 11 2006 2007 2008 2009 2010 2011 2012 2015 O Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms At a Glance Designed Structures and Solutions United States 2012 Revenues: $0.85 Billion* Solutions 84% Europe 2% Canada 7% Latin America 7% Appliance 4% Building & Construction 11% Wire & Cable Sign & Advertising 3% Recreation & Leisure 2% Pool & Spa 1% Distribution & Thermoform 8% Textiles 2% Operating Income % of Sales 2012 Revenue by Industry Segment* Expanding Profits** Wire & Cable 7% Electrical & Electronics 4% Consumer 6% Packaging 23%Industrial 7% Transportation 16% 3% 2.2% 8 ‐ 10% 7% Misc. 1% HealthCare 5% 2012 2015 Target  Page 12 *Pro Forma includes FY2012 results for Spartech (11/03/12 YE) **Pro Forma results include Spartech corporate allocations for FY12 Positioned for Earnings Growth 2015 Target Rev: $5B Adj.  EPS: $2.50 Assumptions • High single digit organic  revenue CAGR • Operating margins in mid range  of 2015 targets • No global recession• No global recession • No investment in incremental  PP&S capacity • Completion of 2‐3 midsize  accretive acquisitions • No divestitures  • Housing starts at 85% of 50 year  norm by 2015 R i f t bl b l 3X N t 2012 $ • Remain comfortably below 3X Net  Debt / EBITDA Page 13 Rev: $3.0B Adj.